Experimentally induced parkinsonism.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002415:Cats; D002531:Cerebellum / Q000378:metabolism / Q000503:physiopathology; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D000882:Haplorhini; D008781:Methyltyrosines / Q000494:pharmacology; D009046:Motor Neurons; D009069:Movement Disorders / Q000503:physiopathology; D018377:Neurotransmitter Agents / Q000378:metabolism*; D009847:Olivary Nucleus / Q000378:metabolism / Q000503:physiopathology; D010300:Parkinson Disease / Q000378:metabolism / Q000503:physiopathology; D012012:Red Nucleus / Q000378:metabolism / Q000503:physiopathology; D013378:Substantia Nigra / Q000378:metabolism; D014202:Tremor / Q000139:chemically induced; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D014793:Visual Cortex / Q000378:metabolism
D008781:Methyltyrosines; D018377:Neurotransmitter Agents; D014446:Tyrosine 3-Monooxygenase; D004296:Dopa Decarboxylase; D004298:Dopamine